Bromazolam(Merck) {SAMPLE(10gm)}

Manufacturer : 

UNITED KINGDOM
Merck Life Science UK Limited
The Old Brickyard
New Rd
Gillingham
Dorset
SP8 4XT

CAS Number : 71368-80-4
Bromazolam is used for indications such as anxiety, to aid sleep and to reduce stimulation caused by another drug such as methamphetamine. Bromazolam is a non subtype selective agonist at the benzodiazepine site of GABAA receptors, with a binding affinity of 2.81nM at the α1 subtype, 0.69nM at α2 and 0.62nM at α5. The “common” dosage range for users of bromazolam was reported to be 1–2 mg, suggesting its potency is similar to alprazolam. Bromazolam is a triazolobenzodiazepine which was first synthesised in 1976, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016.